{"url":"https://lda.senate.gov/api/v1/filings/1d459d29-e267-42ee-a108-a7c99f2bc79c/","filing_uuid":"1d459d29-e267-42ee-a108-a7c99f2bc79c","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2023,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/1d459d29-e267-42ee-a108-a7c99f2bc79c/print/","filing_document_content_type":"text/html","income":null,"expenses":"920000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Samantha Ventimiglia","dt_posted":"2024-01-18T11:31:12-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"50 Northern Avenue","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Boston","registrant_state":"MA","registrant_zip":"02210","registrant":{"id":40027242,"url":"https://lda.senate.gov/api/v1/registrants/40027242/","house_registrant_id":39888,"name":"VERTEX PHARMACEUTICALS INCORPORATED","description":"Global biotechnology company","address_1":"50 Northern Avenue","address_2":null,"address_3":null,"address_4":null,"city":"Boston","state":"MA","state_display":"Massachusetts","zip":"02210","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SAMANTHA VENTIMIGLIA","contact_telephone":"+1 202-264-3511","dt_updated":"2026-07-29T12:53:27.346758-04:00"},"client":{"id":188223,"url":"https://lda.senate.gov/api/v1/clients/188223/","client_id":48,"name":"VERTEX PHARMACEUTICALS INCORPORATED","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-02-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General education about federal policies impacting pharmaceutical development, approval, and reimbursement; Patient access to non-opioid pain medicines; Issues related to FDA drug approval process; Copay accumulators and maximizers, HELP Copays Act (H.R. 830/S. 1375); General education about Alternative Funding Programs; Pandemic All-Hazards Preparedness Act reauthorization, including new authorities requested by FDA.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73549,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"O","last_name":"SCHUMAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143272,"prefix":null,"prefix_display":null,"first_name":"SWARNA","nickname":null,"middle_name":null,"last_name":"VALLURUPALLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145288,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":"BETH","last_name":"CORNWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144970,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":null,"last_name":"MENDELSOHN","suffix":null,"suffix_display":null},"covered_position":"LD, Rep Eshoo (Jan 2013 - May 2015); Congressional Liaison - FDA (May 2015 - Feb 2018); Rep. Harman - Staff Assistant (Jun 2005 - Jun 2006); Rep. Eshoo - Leg. Correspondent, Leg. Assistant, Senior Leg. Assistant (Jan 2005 - Jan 2013).","new":true},{"lobbyist":{"id":146733,"prefix":"ms","prefix_display":"MS.","first_name":"KRISTIN","nickname":"SEUM","middle_name":null,"last_name":"RICHTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to corporate and international tax policy and research and development tax credits, American Innovation and R&D Competitiveness Act (H.R. 2673) and American Innovation and Jobs Act (S. 866)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73549,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"O","last_name":"SCHUMAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143272,"prefix":null,"prefix_display":null,"first_name":"SWARNA","nickname":null,"middle_name":null,"last_name":"VALLURUPALLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"General education about federal policies impacting pharmaceutical development, approval, and reimbursement; Implementation of P.L. 117-169 provisions related to Medicare prescription drugs; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73549,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"O","last_name":"SCHUMAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143272,"prefix":null,"prefix_display":null,"first_name":"SWARNA","nickname":null,"middle_name":null,"last_name":"VALLURUPALLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144970,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":null,"last_name":"MENDELSOHN","suffix":null,"suffix_display":null},"covered_position":"LD, Rep Eshoo (Jan 2013 - May 2015); Congressional Liaison - FDA (May 2015 - Feb 2018); Rep. Harman - Staff Assistant (Jun 2005 - Jun 2006); Rep. Eshoo - Leg. Correspondent, Leg. Assistant, Senior Leg. Assistant (Jan 2005 - Jan 2013).","new":true},{"lobbyist":{"id":145288,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":"BETH","last_name":"CORNWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146733,"prefix":"ms","prefix_display":"MS.","first_name":"KRISTIN","nickname":"SEUM","middle_name":null,"last_name":"RICHTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}